- Report
- June 2025
Germany
From €2211EUR$2,500USD£1,914GBP
- Report
- June 2025
France
From €2211EUR$2,500USD£1,914GBP
- Report
- June 2025
- 81 Pages
From €3051EUR$3,450USD£2,641GBP
- Report
- February 2024
- 141 Pages
Global
€4417EUR$4,995USD£3,824GBP
- Report
- January 2024
- 315 Pages
Global
From €3095EUR$3,500USD£2,679GBP
- Report
- January 2024
- 120 Pages
United States
€3095EUR$3,500USD£2,679GBP
- Report
- November 2023
- 109 Pages
Middle East, Africa
From €2608EUR$2,950USD£2,258GBP
- Report
- November 2023
- 119 Pages
Asia Pacific
From €3051EUR$3,450USD£2,641GBP
- Report
- November 2023
- 122 Pages
Europe
From €3051EUR$3,450USD£2,641GBP
- Report
- November 2023
- 107 Pages
From €2608EUR$2,950USD£2,258GBP
- Report
- November 2023
- 119 Pages
North America
From €2608EUR$2,950USD£2,258GBP
- Report
- November 2023
- 190 Pages
Global
From €4377EUR$4,950USD£3,789GBP
- Report
- November 2023
- 110 Pages
Global
From €2608EUR$2,950USD£2,258GBP
- Report
- March 2023
- 26 Pages
Global
€10832EUR$12,250USD£9,378GBP
- Report
- October 2021
- 180 Pages
United States
From €2211EUR$2,500USD£1,914GBP
- Report
- October 2021
- 70 Pages
United States
From €964EUR$1,090USD£834GBP
- Report
- October 2021
- 45 Pages
United States
From €875EUR$990USD£758GBP
- Report
- April 2021
- 85 Pages
United States
From €1149EUR$1,299USD£994GBP
- Report
- March 2019
- 80 Pages
United States
From €1141EUR$1,290USD£988GBP
- Report
- May 2018
- 106 Pages
Global
From €3095EUR$3,500USD£2,679GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more